NDC11 51267089007
This exact 11-digit normalized identifier can correspond to more than one FDA hyphenation. FDA.report preserves the exact identifier and exposes every structurally valid candidate without guessing.
Possible FDA NDC forms#
| Package NDC | Product root |
|---|---|
| 51267-0890-07 | 51267-0890 |
| 51267-0890-7 | 51267-0890 |
| 51267-890-07 | 51267-890 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Contrave Extended-Release | NALTREXONE HYDROCHLORIDE AND BUPROPION HYDROCHLORIDE | Nalpropion Pharmaceuticals LLC | 485ff360-32c8-11df-928b-0002a5d5c51b | 2025-11-10 | Boxed warning, Warnings, Adverse reactions | 51267-890-07 51267-890 51267089007 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.